We confirmed the HCC-specific efficacy of MBP-11901 through in vitro screening using various human cancer cell lines (Figure 1B), and verified its effectiveness in various HCC cell lines (Table 1). The gene discussed is MBP; the disease is hepatocellular carcinoma.